BioMime Morph | Drug Eluting Stents for Cardiac Arrest | Meril Vascular Intervention

BioMime Morph - Drug Eluting Stents for Cardiac Arrest & Meril Vascular Intervention

biomime_morph
  • Proven benefits of BioMime, now available as a tapered stent system. Treat long diffused lesions with a single stent – one and done.
  • Long diffused lesions are typically treated through multiple overlapping stents, which are associated with higher rate of restenosis/ revascularization.
  • Biomime MorphTM tapers as per vessel anatomy, it helps avoid multiple stent placement thus reducing the probability of fracture and restenosis.
  • Biomime MorphTM is a Sirolimus Eluting Coronary Stent System with an ultra-thin 65 µm strut thickness. This next generation SES has a Novel Hybrid Design with closed cells (on both ends of the stent) & open cells (in the middle) - this allows for Morphology Mediated Expansion for adequate conformability and lesser edge dissections.
  • BioPoly Biodegradable Polymer: 2µm low thickness, stable and elastic polymer
  • Stent design with non-linear S links & Y connectors allows for high flexibility and adequate side branch access.
  • Strut width variability ensures optimal radial strength. 

Benefits

Comments